Royalty Pharma plc (RPRX) |
| 60.96 1.34 (2.25%) 10-16 16:00 |
| Open: | 59.835 |
| High: | 61.31 |
| Low: | 59.635 |
| Volume: | 5,786,552 |
| Market Cap: | 27,144(M) |
| PE Ratio: | 11.61 |
| Exchange: | NASDAQ |
| Industry: | Medical - Pharmaceuticals |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 71.61 |
| Resistance 1: | 61.31 |
| Pivot price: | 57.78 |
| Support 1: | 57.49 |
| Support 2: | 55.13 |
| 52w High: | 64.38 |
| 52w Low: | 35.915 |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Financials
| EPS | 1.880 |
| Book Value | 15.330 |
| PEG Ratio | 1.31 |
| Gross Profit | 5.457 |
| Profit Margin (%) | 32.02 |
| Operating Margin (%) | 19.75 |
| Return on Assets (ttm) | 5.1 |
| Return on Equity (ttm) | 14.0 |
Company news
Sat, 17 Oct 2026
Royalty Pharma plc (RPRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sat, 17 Oct 2026
Royalty Pharma plc (RPRX) stock price, news, quote and history - Yahoo Finance UK
Fri, 16 Oct 2026
Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.23 - MarketBeat
Fri, 16 Oct 2026
Royalty Pharma plc Declares Dividend for the Fourth Quarter of 2026, Payable on December 10, 2026 - marketscreener.com
Fri, 16 Oct 2026
Royalty Pharma declares $0.235 Q4 dividend, payable Dec. 10 - Investing.com
Fri, 16 Oct 2026
Royalty Pharma Announces Fourth-Quarter 2026 Dividend of $0.235 Per Class A Ordinary Share - Quiver Quantitative
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
